Your new experience awaits. Try the new design now and help us make it even better

SYSTEMATIC REVIEW article

Front. Neurol.

Sec. Applied Neuroimaging

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1622274

Research Progress on the Application of Functional Magnetic Resonance Imaging in Cognitive Dysfunction in Patients with Cerebral Small Vessel Disease

Provisionally accepted
Yingying  CaoYingying CaoZhenzhen  LaiZhenzhen LaiJingwen  WangJingwen WangBijun  YeBijun YeWeiqiang  FanWeiqiang FanJiajia  RuanJiajia Ruan*
  • Department of Neurology, Zhejiang Provincial People’s Hospital, Hangzhou, China

The final, formatted version of the article will be published soon.

Cerebral small vessel disease (CSVD) has recently garnered extensive attention owing to its significant disease burden, insidious onset, and the absence of effective specific treatments. Poor lifestyle habits and chronic diseases are closely linked to its occurrence and development, eventually resulting in cognitive dysfunction. Therefore, improvement of lifestyle, stable blood pressure, effective glucose lowering, low-salt and low-fat diet, smoking cessation, moderate exercise and adequate sleep are the keys to preventing cognitive dysfunction in cerebral small-vessel disease. Early prevention and intervention are of significant clinical importance and social value, particularly as CSVD represents a major contributor to cognitive dysfunction in approximately 40 million elderly individuals worldwide. This comprehensive review integrates findings across four functional MRI techniques—diffusion tensor imaging (DTI), resting-state functional MRI (rs-fMRI), magnetic resonance spectroscopy (MRS), and arterial spin labeling (ASL)—to provide a holistic framework connecting structural abnormalities with functional deficits in CSVD. This paper aimed to cover four aspects: an overview of CSVD, the correlation between the clinical manifestations of CSVD and cognitive dysfunction, the neuroradiological features of CSVD, and the application of functional magnetic resonance imaging (fMRI) in CSVD patients with cognitive dysfunction. The integration of these complementary techniques offers unprecedented insights into disease mechanisms, enabling improved early diagnosis, establishment of reliable imaging biomarkers for monitoring disease progression, and development of tailored therapeutic strategies to slow or prevent cognitive decline in affected individuals.

Keywords: Cerebral small vessel disease, functional magnetic resonance imaging, cognitive dysfunction, multimodal neuroimaging, biomarkers

Received: 03 May 2025; Accepted: 17 Jul 2025.

Copyright: © 2025 Cao, Lai, Wang, Ye, Fan and Ruan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jiajia Ruan, Department of Neurology, Zhejiang Provincial People’s Hospital, Hangzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.